NewAmsterdam Pharma N.V.

NASDAQ: NAMS · Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
24.90
-0.64%
Pre-market: Aug 18, 2025, 09:14 AM EDT

NewAmsterdam Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-148.35M -184.7M -232.42M -182.78M -212.22M -212.18M -163.57M -161.48M -120.27M -85.08M -45.19M -3.93M 2.44M 2.47M 3.61M 1.36M -1.57M -1.91M
Depreciation & Amortization
176K 148.7K 110.66K 64.83K 42.99K 50.91K 45.23K 25.32K 19.17K -6.46K -14.74K 3.5K 7K 10.5K 14K 10.75K 7.5K 4.25K
Stock-Based Compensation
47.8M 40.35M 32.5M 28.15M 25.71M 23.08M 22.71M 19.55M 14M 8.91M 1.9M 262.25K 524.5K 786.75K 1.05M 786.75K 524.5K 262.25K
Other Working Capital
1.44M -683.57K -10.09M -2.87M 1.63M 2.15M 472.82K -4.82M -5.34M -2.01M 930.04K 3.82M 1.91M 120.3K 194.23K 158.29K -27.66K 29.59K
Other Non-Cash Items
-26.15M 26.75M 49.31M -1.35M 5.13M -27.46K -26.55K 6.57M 6.53M 10.91M 9.35M -143.9K -4.49M -2.88M -3.91M -3.5M -1.61M -2.37M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
2.4M -11.19M -30.97M -20.56M -17.97M -1.81M 7.09M 63.25M 62.72M 61.89M 62.38M 3.83M 1.92M 124.56K 198.49K 26.29K -291.66K -366.4K
Operating Cash Flow
-124.12M -136.75M -151.09M -146.1M -168.92M -152.04M -130.53M -68.86M -33.78M -521.94K 28.42M -245.18K -133.31K -283.26K -99.75K -2.11M -3.47M -4.65M
Capital Expenditures
-182K -288.75K -630.99K -636.86K -571.2K -374.03K -22.22K -122.78K -113.44K -115.87K -109.43K -5K -10K -15K -20K -18.25K -16.5K -14.75K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-193.34M -9.63M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
37.16M 12.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-62.18M -62.18M -62.18M -2.59M -5.18M -5.18M -5.18M -2.59M n/a n/a n/a 5K 722K 1.44M 2.16M 2.15M 1.44M 726.75K
Investing Cash Flow
-218.53M -59.59M -62.81M -3.23M -5.75M -398.7K -46.89K 2.44M 5.04M -115.87K -109.43K -5K 707K 1.42M 2.13M 2.13M 1.42M 702.25K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
11.59M 12.82M 14M 13.13M 13.27M 14.94M 9.44M 162.12M 161.93M 155.59M 153.35M 5.44M 5.44M 22.68M 39.97M 37.33M 40.18M 25.77M
Financial Cash Flow
466.61M 467.53M 645.42M 188.82M 188.97M 190.43M 8.22M 161.59M 161.39M 155.59M 153.35M 17.21M 34.45M 51.7M 68.99M 54.58M 40.18M 25.77M
Net Cash Flow
133.16M 270.71M 424.95M 45.84M 21.17M 45.66M -109.55M -79.45M -47.01M -24.62M -696.05K -165.69K -78.49K -277.06K -36.44K 773.45K 2.23M 3.89M
Free Cash Flow
-124.3M -137.04M -151.72M -146.73M -169.49M -152.41M -130.55M -68.98M -33.89M -637.81K 28.31M -250.18K -143.31K -298.26K -119.75K -2.13M -3.49M -4.66M